University of Florida Research Foundation;ABBVIE, INC.
发明人:
SOREN NIELSEN,THOMAS ENGELBRECHT NORDKILD JONASSEN,SAMINA KHAN,MARK T. HOUSER,IB BO LUMHOLTZ,MICHAEL BECKERT,THOMAS BEAVER
申请号：
US14069045
公开号：
US20140121164A1
申请日:
2013.10.31
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease.
